News | February 12, 2009

Endologix’s New IntuiTrakEndovascular AAA System Featured at International Congress

February 12, 2009 - Endologix Inc. yesterday said a live-case demonstration of its new IntuiTrak Delivery System was featured at the International Congress XXII Endovascular Interventions conference in Scottsdale, AZ.

The procedure was performed by Zvonimir Krajcer, M.D., co-director of the peripheral vascular disease service at the Texas Heart Institute; Edward Diethrich, M.D., medical director and founder of the Arizona Heart Institute; and Venkatesh G. Ramaiah, M.D., vascular surgeon at the Arizona Heart Hospital. The endovascular AAA procedure was successfully performed with a percutaneous approach and local anesthesia.

IntuiTrak was developed for the minimally invasive delivery and deployment of the Powerlink stent graft. The device is currently in limited market release following FDA approval in October 2008. The company said IntuiTrak’s design and deployment mechanism simplifies standard vascular delivery of the Powerlink device and provides exceptional accuracy and control. The low-profile delivery system features enhanced flexibility, advanced hemostasis control and a hydrophilic coating to facilitate smooth delivery, particularly in patients with limited or difficult vascular access, the company said. Additionally, the delivery catheter has an integrated sheath that minimizes the need to exchange introducers, thereby having the potential to minimize vessel trauma and reduce overall procedure time.
“Due to its low-profile and integrated sheath, IntuiTrak is ideal for the percutaneous treatment of patients with AAA,” said Dr. Krajcer. “I have used the new device in eight cases so far, and have experienced 100 percent technical success and exceptional patient outcomes.”

For more information: www.endovascularcongress.org, www.endologix.com

Related Content

Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
Gore Announces First-in-Human Use of Gore TAG Conformable Thoracic Stent Graft
News | Stent Grafts| July 17, 2017
W. L. Gore & Associates Inc. announced the first patient implant of the Gore TAG Conformable Thoracic Stent Graft...
Philips Announces Relaunch of Pioneer Plus IVUS-Guided Catheter
News | Chronic Total Occlusion (CTO)| June 28, 2017
June 28, 2017 — Royal Philips recently announced the relaunch of its Pioneer Plus...
New Paper Highlights Success of Advanced Treatments in Complex Aortic Aneurysm Repair
News | Endovascular Aortic Repair| May 23, 2017
Significant success has been achieved in treating complex proximal aneurysms using a combination of fenestrated and...
News | Stent Grafts| April 06, 2017
Endologix Inc. announced that the first patients were treated in the Expanding Patient Applicability with Polymer...
Teleflex, FDA 510k clearance, TrapLiner Catheter, U.S. launch
Technology | Catheters| March 02, 2017
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
Technology | Radial Access| February 17, 2017
Medtronic plc announced that its coronary portfolio will now include the DxTerity Diagnostic Angiography Catheter line...
Mercator MedSystems, DANCE trial data, ISET, LINC, Bullfrog Micro-Infusion Device
News | Peripheral Artery Disease (PAD)| February 15, 2017
Mercator MedSystems announced that the national co-principal investigators of the company’s DANCE trial each presented...
Gore, Viabahn VBX Balloon Expandable Endoprosthesis, stent graft, iliac artery, FDA approval
Technology | Stent Grafts| January 31, 2017
W. L. Gore & Associates (Gore) announced that the Gore Viabahn VBX Balloon Expandable Endoprosthesis (VBX Stent...
Overlay Init